Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda (RMDA) Financial Statements
Annual financial statement highlights for Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda, in Egyptian pounds (EGP) covering fiscal years 2017–2025. Figures are updated weekly from EGX filings via TradingView.
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Total assets | Total debt | DPS |
|---|---|---|---|---|---|---|---|
| 2025 | 4.1B | 268.61M | 0.1336 | -199.57M | 5.34B | 2.41B | 0.03 |
| 2024 | 2.77B | 363.84M | 0.1827 | -371.85M | 4.31B | 1.57B | 0.0804 |
| 2023 | 1.92B | 223.5M | 0.1125 | -135.54M | 3.22B | 1.11B | 0.0507 |
| 2022 | 1.48B | 229.08M | 0.1147 | -5.03M | 2.77B | 930.18M | 0.00 |
| 2021 | 1.25B | 166.39M | 0.0826 | 188.68M | 2.42B | 879.94M | 0.0049 |
| 2020 | 960.17M | 97.48M | 0.0484 | -249.31M | 2.25B | 929.56M | 0.00 |
| 2019 | 893.97M | 82.39M | 0.0409 | -28.44M | 1.87B | 627.72M | 0.00 |
| 2018 | 805.21M | 129.02M | 0.0765 | -213.99M | 1.22B | 588.13M | — |
| 2017 | 628.45M | 89.45M | 0.053 | -58.88M | 804.42M | 355.23M | — |
All figures in EGP. Source: company disclosures to the Egyptian Exchange via TradingView; updated weekly.